Trump Administration Proposes Stronger Insurer Price Transparency Requirements: An Analytical Review

By Elena Pak, Credentialing Department, WCH

The Trump administration has introduced a significant proposed rule aimed at strengthening price transparency requirements for health insurers and health plans, marking the latest chapter in a multiyear effort to demystify healthcare pricing for American consumers. Announced in late April 2025, the proposal represents both a continuation of and a course correction to transparency initiatives that began during the first Trump administration. While the original 2021 requirements aimed to flood the market with pricing data, this new proposal acknowledges a critical implementation challenge: too much unorganized information can be as opaque as no information at all.

The proposed rule arrives at a pivotal moment in healthcare policy, as stakeholders grapple with the reality that simply requiring data disclosure does not automatically translate to meaningful price transparency or consumer empowerment. This analysis examines the key provisions of the proposed regulation, evaluates its potential impact on insurers and patients, and considers whether these modifications represent a genuine advance toward actionable price transparency or merely administrative refinement of an underutilized system.

Background: The Evolution of Healthcare Price Transparency

The foundation for current price transparency requirements was established during the first Trump administration, when the Department of Health and Human Services finalized regulations in 2020 requiring both hospitals and insurers to post machine-readable files containing detailed pricing information for healthcare services. These requirements took effect in January 2021, with the stated goal of enabling patients to compare prices across facilities and encouraging market-driven cost competition among providers.

The underlying theory was economically straightforward: armed with transparent pricing information, consumers would gravitate toward lower-cost, high-quality providers, creating competitive pressure that would drive down healthcare costs across the system. However, the practical implementation has proven considerably more complex than the policy vision suggested.

Hospital compliance with transparency requirements has been notably inconsistent, with many facilities either failing to post required data or posting information in formats that are technically compliant but practically unusable for most consumers. Enforcement has been limited, and penalties for non-compliance have been modest relative to hospital operating budgets. More fundamentally, research has yet to demonstrate that patients are meaningfully using the available pricing data to inform their healthcare decisions, raising questions about whether transparency alone can reshape healthcare markets.

Insurers, by contrast, have demonstrated stronger compliance rates. Research published in October 2024 by Turquoise Health found that insurers and health plans generally make accurate negotiated rate data available, though the research organization cautioned that only state or federal regulators can make definitive compliance determinations. Yet even among compliant insurers, significant implementation challenges have emerged, particularly regarding the organization, accessibility, and usability of the posted data.

Key Provisions of the Proposed Rule

The Trump administration’s newly proposed regulation attempts to address several practical shortcomings of the existing transparency framework while maintaining the fundamental requirement that insurers disclose negotiated rates.

File Size Reduction and Reporting Frequency

Perhaps the most significant operational change involves reducing the size and update frequency of machine-readable files. The administration identified file size as “the most prominent challenge” of the current system, noting that many insurer files have become so large and unwieldy that they are difficult for both patients and healthcare technology companies to process effectively. Some files exceed multiple gigabytes, creating technical barriers to access and analysis.

To address this issue, the proposed rule would reduce the reporting frequency for in-network rates from monthly to quarterly updates, decreasing the volume of data insurers must generate and post. Additionally, insurers would no longer be required to post in-network rates for services that providers are “unlikely” to perform, eliminating extraneous data points that add size without adding meaningful consumer value.

Network-Based File Organization

The proposed rule also mandates that insurers reorganize their rate files by provider network rather than by individual plan. This structural change addresses a significant ambiguity in current regulations: while insurers often operate national, regional, and statewide networks, existing rules have not required clear identification of which posted files correspond to which networks. Consequently, insurers have tended to compile comprehensive data dumps that aggregate information across multiple networks, making it difficult for consumers to identify which rates actually apply to their specific plan and geographic area.

By requiring network-based organization—similar to how most hospitals report their data—the rule aims to create more intuitive file structures that align with how consumers actually access care. A patient with a regional HMO network, for example, would be able to access pricing data specific to that network without wading through irrelevant information about providers in other parts of the country.

Enhanced Rate Change Tracking

The proposed rule introduces a new requirement for insurers to track and report how prices change over time for certain in-network health services. This longitudinal data element represents an important evolution beyond static price snapshots, potentially enabling consumers and researchers to identify pricing trends, seasonal variations, and the impact of contract renegotiations between insurers and providers.

Alternative Access Methods

Recognizing that not all patients have reliable internet access or the technical capacity to navigate machine-readable files, the proposed rule would require insurers to make rate information available by phone or paper upon request. This provision acknowledges that digital transparency alone may exacerbate healthcare disparities if it creates information access barriers for patients with limited connectivity or digital literacy.

Analysis: Potential Impact and Limitations

The proposed rule represents a pragmatic acknowledgment that the first generation of price transparency requirements, while well-intentioned, created implementation challenges that undermined their utility. By attempting to make data more organized, relevant, and accessible, the Trump administration is responding to legitimate critiques of the existing system.

Potential Benefits

From an operational standpoint, reducing file sizes and reporting frequency should decrease administrative burden on insurers while simultaneously improving data usability for patients and third-party technology developers. Smaller, better-organized files are more likely to be integrated into consumer-facing price comparison tools, which could finally enable the market-driven cost competition that transparency advocates have long envisioned.

The network-based reorganization requirement is particularly valuable, as it addresses one of the most confusing aspects of current transparency data. Patients who understand they have a specific network plan will be able to access relevant pricing information without sorting through rates that do not apply to their coverage.

Tracking price changes over time adds an important analytical dimension that could reveal patterns in insurer-provider negotiations and highlight services where costs are rising most rapidly. This longitudinal perspective may prove valuable for researchers, policymakers, and consumer advocates seeking to understand healthcare cost dynamics.

Persistent Challenges

However, the proposed rule does not address several fundamental barriers to effective price transparency. Most significantly, it does not resolve the question of whether patients will actually use pricing data to guide their healthcare decisions. Research to date has found limited evidence of widespread consumer engagement with transparency tools, suggesting that information availability alone may be insufficient to change behavior.

Multiple factors constrain patient price shopping in healthcare markets. Urgent or emergency care situations leave no time for price comparison. Many patients prioritize established relationships with trusted providers over cost considerations. Health literacy barriers may prevent patients from understanding what services they need or how to interpret pricing information. Insurance benefit designs with out-of-pocket maximums can reduce price sensitivity once patients have met their deductibles.

Additionally, the proposal maintains machine-readable file requirements that, even when better organized, remain technically challenging for average consumers to navigate without intermediary technology tools. The success of this transparency framework depends substantially on third-party developers creating user-friendly applications that translate raw data into actionable consumer insights—a market response that has been slower to materialize than many anticipated.

The rule also does not address hospital price transparency compliance, which remains problematic despite parallel requirements. Without comprehensive pricing visibility across both the insurance and provider sides of healthcare transactions, patients still face significant information gaps.

Policy Implications and Future Considerations

The Trump administration’s continued focus on price transparency signals a bipartisan recognition that healthcare cost concerns remain central to American healthcare policy. CMS Administrator Dr. Mehmet Oz characterized the proposed rule as a “giant step” toward simplifying healthcare costs, framing the regulation within the administration’s broader healthcare reform agenda.

The February 2025 executive order that prompted this rulemaking directed federal agencies to “rapidly implement and enforce” healthcare price transparency regulations and to “take all necessary steps” to improve transparency requirements. This language suggests that additional refinements or enforcement actions may follow if the current proposal proves insufficient.

Looking forward, the effectiveness of this revised transparency framework will likely depend on several factors beyond regulatory text. Robust enforcement will be essential to ensure compliance and deter facilities from posting technically compliant but practically useless data. Investment in consumer education and health literacy will be necessary to help patients understand and use pricing information. Development of sophisticated but user-friendly technology tools will be critical to translate data into actionable insights.

Policymakers may also need to consider complementary reforms that address the underlying market dynamics that drive healthcare pricing. Transparency alone cannot solve problems rooted in provider consolidation, limited competition in many healthcare markets, the complexity of bundled services, or the misalignment of incentives between patients, providers, and payers.

---

The Trump administration’s proposed price transparency rule represents an iterative improvement on existing requirements, addressing legitimate implementation challenges while maintaining the fundamental commitment to healthcare pricing disclosure. By reducing file sizes, reorganizing data structures, and creating alternative access pathways, the proposal attempts to transform transparency from a technical compliance obligation into a practical consumer tool.

However, the ultimate success of these requirements will depend not only on regulatory refinement but on broader ecosystem development—including technology innovation, consumer engagement, market competition, and sustained enforcement. Price transparency is a necessary but insufficient condition for healthcare cost control. As this policy continues to evolve, stakeholders should maintain realistic expectations about what disclosure alone can achieve while remaining committed to the principle that patients deserve to understand the costs of their care before receiving treatment.

The comment period for this proposed rule will provide an important opportunity for insurers, patient advocates, technology developers, and other stakeholders to identify potential implementation challenges and suggest additional improvements. Whether this iteration of price transparency requirements finally delivers on the promise of empowered, cost-conscious healthcare consumers remains to be seen, but the administration’s willingness to adjust its approach based on real-world experience represents a constructive step in healthcare policy development.

Sources

Healthcare Dive. “Trump administration proposes stronger insurer price transparency requirements.” April 2025.

Turquoise Health. “Health Plan Price Transparency Compliance Research.” October 2024.

U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services. “Transparency in Coverage Final Rule.” November 2020.

Executive Order on Healthcare Price Transparency. The White House. February 2025.

Centers for Medicare & Medicaid Services. “Proposed Rule: Strengthening Price Transparency Requirements for Health Plans.” April 2025.